Last reviewed 26 August 2026
It is the question this company is asked more than any other: other research-peptide sites list semaglutide, tirzepatide and their relatives, so why does NovoVita’s shop not? The answer is not sourcing. It is a position about the law, about what the enforcement record shows, and about what kind of supplier this is — and it is worth setting out in full, because the sites that do sell these compounds rarely explain what they are actually selling.
Every statement here is a statement about a rule, a document or a public record; none is a statement about what any compound does.
What semaglutide is, in regulatory terms
Semaglutide is the active substance in Ozempic and Wegovy — authorised medicines, and prescription-only ones. The MHRA states the classification plainly: Semaglutide and liraglutide are prescription only medicines.
The consequence sits in regulation 214 of the Human Medicines Regulations 2012: A person may not sell or supply a prescription only medicine except in accordance with a prescription given by an appropriate practitioner.
There is no research-supplier exception to that sentence, and no disclaimer that rewrites it.
The disclaimer point matters, because the grey market leans on one. Under Article 1(2) of Directive 2001/83/EC a product is a medicinal product not only by what it contains but by how it is presented — and the MHRA’s Guidance Note 8, the agency’s published guide to what counts as a medicinal product, works through exactly this borderline. A vial of a prescription medicine’s active substance, offered on a consumer-facing shop with a basket button, is presented for supply to the public whatever the label says about research. Writing “research use only” above an add-to-basket button does not move a product across that line; it documents that the seller knows the line is there.
What the enforcement record shows
The market that sells semaglutide without a prescription is the same market the MHRA has been seizing product from. In October 2023 the agency reported it had seized 369 potentially fake Ozempic pens since January 2023
, alongside reports of people hospitalised after using pens obtained without prescription — serious side effects reported of those hospitalised, including hypoglycaemic shock and coma
, a pattern consistent with pens containing the wrong substance entirely. Its advice was categorical: Buying prescription-only medicines online without a prescription poses a direct danger to health.
Nothing in that record distinguishes the honest grey-market seller from the counterfeiter, because from the buyer’s side there is no way to tell. That is the practical meaning of prescription control: the supply chain that carries a prescription medicine to a patient is audited end to end, and everything outside it is unverifiable by construction.
Where that leaves this site
Semaglutide, tirzepatide and the other named medicines are not offered for sale on this site, and never have been. The semaglutide and tirzepatide entries in our compound library exist because a reference that only covered its own shelf would be a catalogue, not a reference — they document identity, the published literature and the regulatory position, with every citation resolved against its source. A library entry is not a product, it carries no price and no basket, and it is not an invitation to consume anything.
Somatropin — human growth hormone — sits one step further out again: beyond being a prescription-only medicine it is a Class C controlled drug under Schedule 4 Part II of the Misuse of Drugs Regulations 2001, with its own criminal framework attached. The same answer applies with more force.
Why a supplier would hold this line
Partly because it is the law, and a company that publishes its registered number invites you to hold it to that. But also because the alternative corrodes everything else a research supplier says. A catalogue that sells an unauthorised copy of a prescription medicine next to a laboratory reagent is asking you to believe its purity claims, its testing claims and its research-use framing while demonstrating, one product over, that its framing bends when a compound sells well enough. We would rather the framing did not bend. What we supply is specified, tested and sold for laboratory research; what a prescriber supplies is medicine; and a site that blurs the two is not describing either honestly.
If your interest is treatment
Semaglutide and tirzepatide are available in the United Kingdom and Ireland through the routes built for them: a prescriber, a pharmacy, a supply chain that is audited. If that is what brings you here, nothing we sell is a route to it, and a conversation with a GP or pharmacist is the step that is.
What this article does not settle
Regulatory positions move — classifications change and guidance is reissued, so check the linked documents rather than a remembered summary. Everything NovoVita supplies is for laboratory research use only and is not for human or veterinary use; an entry in the compound library is documentation of the published record, not a product. This is analysis, not legal advice.
Sources
- Human Medicines Regulations 2012, regulation 214 — sale or supply of prescription-only medicines.
- MHRA, MHRA warns of unsafe fake weight loss pens (26 October 2023) — the seizure figures, the hospitalisation reports and the prescription-only classification quoted above.
- MHRA, Guidance Note 8: a guide to what is a medicinal product — the presentation test.
- Directive 2001/83/EC on the Community code relating to medicinal products for human use, Article 1(2).
- Misuse of Drugs Regulations 2001, Schedule 4 — somatropin’s controlled-drug status.
- NovoVita, Are research peptides legal in the UK? — the wider framework this article sits inside.